drugset / Trial / NCT00730977
A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device
NaSingle-groupOpen-label
Summary
A novel dry powder inhaler device will be used to administer mannitol to healthy subjects and subjects with bronchiectasis in single doses higher than previously given.The main objective is to assess tolerability of these doses using the new device.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mannitol | Diagnostic / imaging agent | 40 mg | Inhaled |
| Subject | Mannitol | Diagnostic / imaging agent | 70 mg | Inhaled |
| Subject | Mannitol | Diagnostic / imaging agent | 100 mg | Inhaled |